IMMUNOMORPHOLOGICAL CHARACTERISTICS OF CERVICAL CANCER AND THEIR INTERRELATIONSHIPS

ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-11 311 IMMUNOMORPHOLOGICAL CHARACTERISTICS OF CERVICAL CANCER AND THEIR INTERRELATIONSHIPS Abraykulov Ilhom Ramazonovich Assistant of the Department of Oncology, Ophthalmology, Termez Branch of the Tashkent Medical Academy Otorhinolaryngology and Medical Radiology. Annotation: Cervical cancer remains one of the most prevalent malignancies among women worldwide, with complex immunomorphological features that influence its progression, diagnosis, and treatment outcomes. This article explores the immunomorphological characteristics of cervical cancer, focusing on the structural and functional changes in tumor cells and the surrounding microenvironment. Special attention is given to the role of immune cells, cytokines, and molecular markers that reflect the immune response and tumor aggressiveness. The interrelationships between these parameters are analyzed to better understand the mechanisms of tumor development, invasion, and metastasis. The findings highlight the significance of immunomorphological assessment in improving diagnostic accuracy, prognostic evaluation, and the selection of effective therapeutic strategies for patients with cervical cancer. Keywords: cervical cancer, immunomorphology, tumor microenvironment, immune response, molecular markers, pathogenesis, prognosis. INTRODUCTION Cervical cancer is one of the leading causes of morbidity and mortality among women, particularly in developing countries. Despite advances in preventive measures such as vaccination against human papillomavirus (HPV) and improved screening programs, cervical cancer continues to pose a major public health challenge. The disease develops through a multistage process involving persistent HPV infection, cellular dysplasia, and malignant transformation of epithelial cells. In recent years, the study of immunomorphological characteristics of cervical cancer has gained significant attention, as it provides insights into the interactions between tumor cells and the host immune system. The immune microenvironment plays a crucial role in tumor initiation, progression, and metastasis. Immune cells such as lymphocytes, macrophages, and dendritic cells, along with cytokines and molecular markers, form a complex regulatory network that affects tumor behavior and patient outcomes.Understanding the interrelationships between immunological and morphological features of cervical cancer can help identify prognostic indicators and therapeutic targets. Immunomorphological analysis not only aids in assessing tumor aggressiveness but also contributes to the development of personalized treatment strategies, including immunotherapy. Therefore, the present study aims to describe the main immunomorphological characteristics of cervical cancer and to analyze their interconnections in the context of tumor progression and prognosis. Materials and Methods The present study was conducted on biopsy and surgical specimens obtained from patients diagnosed with various stages of cervical cancer. The material included samples of squamous cell carcinoma, adenocarcinoma, and precancerous lesions such as cervical intraepithelial neoplasia (CIN). All samples were collected with informed consent and processed according to standard histological and immunohistochemical protocols. For histomorphological analysis, tissue samples were fixed in 10% ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-11 312 neutral buffered formalin, embedded in paraffin, sectioned at 4–5 μm thickness, and stained with hematoxylin and eosin (H&E) to evaluate cellular and structural changes. Microscopic examination focused on features such as nuclear atypia, mitotic activity, stromal reaction, and vascular invasion. Immunohistochemical studies were carried out to identify immune cell populations and molecular markers associated with tumor progression. Primary antibodies were used against CD3, CD4, CD8 (T-lymphocyte markers), CD68 (macrophage marker), Ki-67 (proliferation marker), p53 (tumor suppressor protein), and PD-L1 (immune checkpoint molecule). Visualization was achieved using the peroxidase-antiperoxidase (PAP) method with diaminobenzidine (DAB) as a chromogen. Quantitative evaluation of immunopositive cells was performed by counting positive cells per 100 tumor cells in five random high-power fields (HPF). The intensity and distribution of immune infiltration were scored semi-quantitatively (low, moderate, or high). The obtained data were statistically processed using descriptive and comparative analyses to identify correlations between morphological features, immune parameters, and clinical stages of the disease. This comprehensive approach made it possible to establish the relationship between immunological activity and the degree of morphological differentiation of cervical cancer, providing a deeper understanding of its pathogenetic mechanisms. Results The analysis of histological specimens revealed distinct morphological variations among different stages and histological types of cervical cancer. In early stages, tumor cells exhibited moderate nuclear atypia, preserved cellular polarity, and mild stromal infiltration. In advanced cases, however, cells demonstrated pronounced pleomorphism, hyperchromatic nuclei, high mitotic index, and extensive stromal desmoplasia. Areas of necrosis and vascular invasion were frequently observed in poorly differentiated tumors. Immunohistochemical examination showed significant differences in the density and distribution of immune cells within the tumor microenvironment. CD3⁺ and CD8⁺ Tlymphocytes were predominantly located in the peritumoral zones, indicating an active cytotoxic immune response. In contrast, CD4⁺ helper T-cells and CD68⁺ macrophages were distributed both in the stroma and within tumor nests, suggesting their involvement in tumor-associated inflammation and immune regulation. The expression of Ki-67, a marker of proliferative activity, was markedly increased in high-grade tumors, confirming their rapid growth potential. Similarly, overexpression of p53 protein was detected in the majority of invasive carcinoma samples, reflecting disrupted cell cycle regulation and genomic instability. Notably, tumors with strong PD-L1 expression were associated with reduced CD8⁺ lymphocytic infiltration, suggesting an immune-evasive phenotype. Statistical analysis revealed a strong correlation between immune marker expression and tumor differentiation. High Ki-67 and PD-L1 expression, combined with low CD8⁺ infiltration, were significantly associated with advanced stages and lymphovascular invasion (p < 0.05). Conversely, cases with abundant CD8⁺ T-cell infiltration and moderate PD-L1 expression tended to exhibit slower progression and better differentiation. Overall, the findings indicate that the immunomorphological profile of cervical cancer reflects the balance between immune activation and tumor immune evasion. The interaction between tumor cells and immune components defines the biological behavior of the neoplasm and may serve as a reliable predictor of prognosis and therapeutic response. Discussion The results of the present study highlight the significant role of immunomorphological interactions in the progression and clinical behavior of cervical cancer. The observed variations in immune cell ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-11 313 infiltration and expression of molecular markers suggest that cervical carcinogenesis is not only driven by genetic alterations but also modulated by the tumor microenvironment and the host immune response. The presence of CD3⁺ and CD8⁺ T-lymphocytes in the peritumoral regions indicates an attempt by the immune system to recognize and destroy malignant cells. However, the reduced number of these cytotoxic cells in advanced stages, along with the overexpression of PD-L1, demonstrates the tumor’s ability to evade immune surveillance. This finding aligns with previous studies that describe PD-L1 as a key immune checkpoint molecule enabling tumor cells to suppress T-cell activity and promote immune tolerance. The increased expression of Ki-67 and p53 markers observed in this study correlates with high proliferative activity and cellular atypia, confirming their role as indicators of tumor aggressiveness. These results support earlier reports that link elevated Ki67 levels with poor differentiation and unfavorable prognosis in cervical carcinoma. Similarly, abnormal p53 accumulation reflects disrupted apoptosis and genomic instability, contributing to malignant transformation and progression. The abundance of CD68⁺ macrophages in tumor tissues suggests a dual role of these immune cells in cancer. While macrophages may initially participate in antitumor defense, chronic stimulation can lead to their polarization into tumor-associated macrophages (TAMs), which facilitate angiogenesis, tissue remodeling, and immune suppression. This phenomenon was evident in our samples, where increased macrophage infiltration was associated with advanced tumor stages and vascular invasion. Taken together, these findings demonstrate that the balance between immune activation and suppression determines the morphological and clinical course of cervical cancer. Tumors characterized by strong immune infiltration and lower PD-L1 expression tend to exhibit a more favorable outcome, whereas those with high PD-L1 expression, elevated Ki-67 index, and limited cytotoxic lymphocyte presence display aggressive behavior and poor prognosis. Therefore, immunomorphological assessment can serve as an essential tool not only for diagnostic and prognostic purposes but also for identifying patients who may benefit from targeted immunotherapy. The integration of immunohistochemical profiling into routine pathological evaluation could enhance personalized treatment planning and improve survival outcomes for patients with cervical cancer. Conclusion The conducted study demonstrates that the immunomorphological characteristics of cervical cancer are closely interconnected with the degree of tumor differentiation, aggressiveness, and clinical stage of the disease. The presence and activity of immune cells—particularly CD3⁺, CD4⁺, CD8⁺ lymphocytes, and CD68⁺ macrophages—reflect the dynamic interaction between the host immune system and tumor tissue. Increased expression of Ki-67 and p53 indicates high proliferative potential and genomic instability, while overexpression of PD-L1 suggests an active immune escape mechanism. These findings confirm that cervical cancer development and progression depend not only on the malignant potential of epithelial cells but also on the state of the immune microenvironment. The identification of immunomorphological markers enables a more accurate evaluation of tumor behavior, facilitates prognosis, and provides valuable guidance for the selection of personalized therapeutic approaches, including immunotherapy. In conclusion, immunomorphological assessment should be considered a vital component of modern oncopathological diagnostics, offering new perspectives for improving patient management and longterm outcomes in cervical cancer. REFERENCES: ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-11 314 1. Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., & Murakami, I. (2015). Human papillomavirus molecular biology and disease association. Reviews in Medical Virology, 25(S1), 2–23. 2. zur Hausen, H. (2009). Papillomaviruses in the causation of human cancers – a brief historical account. Virology, 384(2), 260–265. 3. Tjalma, W. A., Fiander, A., Reich, O., et al. (2013). Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. International Journal of Cancer, 132(4), 854–867. 4. Wu, Y., Guo, H., Zeng, Q., et al. (2020). Immune microenvironment and immunotherapy of cervical cancer. Frontiers in Immunology, 11, 575765. 5. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2), 69–90. 6. Lechner, M., & Thierauf, J. (2019). Role of the immune system in HPV-associated head and neck and cervical cancers. Frontiers in Oncology, 9, 1074. 7. Piersma, S. J. (2011). Immunosuppressive tumor microenvironment in cervical cancer patients. Cancer Microenvironment, 4(3), 361–375. 8. Li, H., & Liu, F. (2021). PD-L1 expression and tumor-infiltrating lymphocytes in cervical carcinoma: Correlation with clinical outcomes. BMC Cancer, 21(1), 1–9.